Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0267647
Abstract: Rifaximin and lactulose are widely used in patients with hepatic encephalopathy (HE); however, data on whether the combined use of rifaximin and lactulose could yield additional benefits for patients with HE are limited and inconclusive.… read more here.
Keywords: rifaximin lactulose; rifaximin; lactulose alone; systematic review ... See more keywords
Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2023.1091167
Abstract: Background Minimal hepatic encephalopathy (MHE) is an early stage in the pathogenesis of hepatic encephalopathy. Intestinal microbiota is involved in the pathogenesis of hepatic encephalopathy and has become an important therapeutic target. Since there is… read more here.
Keywords: hepatic encephalopathy; microbiota; probiotics rifaximin; mhe patients ... See more keywords